1 / 4

Brain Injury Pipeline Review, H2 Global Share and Size, Trends and Growth, Segment Forecast to 2015

This report provides comprehensive information on the therapeutic development for Brain Injury, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Brain Injury and special features on late-stage and discontinued projects.

buntypatil
Télécharger la présentation

Brain Injury Pipeline Review, H2 Global Share and Size, Trends and Growth, Segment Forecast to 2015

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Hexa Reports Market Research Reports and Insightful Company Profiles Brain Injury Pipeline Review, H2 Global Share and Size, Trends and Growth, Segment Forecast to 2015 Global Markets Direct's, 'Brain Injury - Pipeline Review, H2 2015', provides an overview of the Brain Injury's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Brain Injury, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Brain Injury and special features on late-stage and discontinued projects. Browse Detail Report With TOC @ http://www.hexareports.com/report/brain-injury-pipeline-review- h2-2015/details Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

  2. Hexa Reports Market Research Reports and Insightful Company Profiles Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Scope The report provides a snapshot of the global therapeutic landscape of Brain Injury The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities The report reviews key players involved in the therapeutics development for Brain Injury and enlists all their major and minor projects The report summarizes all the dormant and discontinued pipeline projects A review of the Brain Injury products under development by companies and universities/research institutes based on information derived from company and industry- specific sources Pipeline products coverage based on various stages of development ranging from pre- registration till discovery and undisclosed stages A detailed assessment of monotherapy and combination therapy pipeline projects Coverage of the Brain Injury pipeline on the basis of target, MoA, route of administration and molecule type Latest news and deals relating related to pipeline products Request A Sample copy of This Report @ http://www.hexareports.com/sample/46606 Reasons to buy 1.Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies 2.Identify emerging players with potentially strong product portfolio and create effective counter- strategies to gain competitive advantage 3.Develop strategic initiatives by understanding the focus areas of leading companies 4.Identify and understand important and diverse types of therapeutics under development for Brain Injury 5.Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

  3. Hexa Reports Market Research Reports and Insightful Company Profiles 6.Devise corrective measures for pipeline projects by understanding Brain Injury pipeline depth and focus of Indication therapeutics 7.Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope 8.Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline Browse All Pharmaceuticals & Healthcare Market Research Related Reports @ http://www.hexareports.com/category/pharmaceuticals-and-healthcare-market Table Of Content List of Tables List of Figures Introduction Global Markets Direct Report Coverage Brain Injury Overview Therapeutics Development Pipeline Products for Brain Injury - Overview Pipeline Products for Brain Injury - Comparative Analysis Brain Injury - Therapeutics under Development by Companies Brain Injury - Therapeutics under Investigation by Universities/Institutes Brain Injury - Pipeline Products Glance Early Stage Products Brain Injury - Products under Development by Companies Brain Injury - Products under Investigation by Universities/Institutes Brain Injury - Companies Involved in Therapeutics Development Acorda Therapeutics, Inc. Biogen, Inc. Chiesi Farmaceutici SpA Faron Pharmaceuticals Oy FibroGen, Inc. Virogenomics, Inc. Brain Injury - Therapeutics Assessment Assessment by Monotherapy Products Assessment by Target Assessment by Mechanism of Action Assessment by Route of Administration Assessment by Molecule Type Drug Profiles Enzyme to Inhibit Chondroitin Sulfate Proteoglycan for Spinal Cord Injury and Brain Injury - Drug Profile Product Description Mechanism of Action

  4. Hexa Reports Market Research Reports and Insightful Company Profiles R&D Progress FG-4497 - Drug Profile Product Description Mechanism of Action R&D Progress Interferon beta-1a - Drug Profile Product Description Mechanism of Action R&D Progress Peptide to Inhibit Pannexin-1 for Brain Injury - Drug Profile Product Description Mechanism of Action R&D Progress PRE-084 - Drug Profile Product Description Mechanism of Action R&D Progress Browse Full Report @ http://www.hexareports.com/report/brain-injury-pipeline-review-h2- 2015/details About Us: Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Information: Ryan Shaw Felton Office Plaza, 6265 Highway 9, Felton, California, 95018, United States Phone Number 1-800-489-3075 Email Us: sales@hexareports.com Our Website: http://www.hexareports.com/

More Related